HFG Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253K | Buy |
649
+2
| +0.3% | +$778 | 0.2% | 80 |
|
|
2025
Q1 | $281K | Buy |
647
+3
| +0.5% | +$1.3K | 0.24% | 70 |
|
|
2024
Q4 | $238K | Sell |
644
-263
| -29% | -$97.1K | 0.21% | 79 |
|
|
2024
Q3 | $471K | Buy |
907
+2
| +0.2% | +$1.04K | 0.42% | 50 |
|
|
2024
Q2 | $490K | Buy |
905
+2
| +0.2% | +$1.08K | 0.46% | 48 |
|
|
2024
Q1 | $468K | Sell |
903
-45
| -5% | -$23.3K | 0.42% | 54 |
|
|
2023
Q4 | $447K | Buy |
948
+2
| +0.2% | +$943 | 0.43% | 52 |
|
|
2023
Q3 | $412K | Buy |
946
+50
| +6% | +$21.8K | 0.45% | 55 |
|
|
2023
Q2 | $398K | Buy |
896
+2
| +0.2% | +$889 | 0.42% | 54 |
|
|
2023
Q1 | $411K | Buy |
894
+2
| +0.2% | +$919 | 0.47% | 50 |
|
|
2022
Q4 | $457K | Buy |
892
+2
| +0.2% | +$1.03K | 0.54% | 45 |
|
|
2022
Q3 | $404K | Sell |
890
-283
| -24% | -$128K | 0.56% | 43 |
|
|
2022
Q2 | $566K | Buy |
1,173
+1
| +0.1% | +$483 | 0.76% | 41 |
|
|
2022
Q1 | $575K | Sell |
1,172
-197
| -14% | -$96.7K | 0.66% | 38 |
|
|
2021
Q4 | $635K | Buy |
+1,369
| New | +$635K | 0.72% | 38 |
|